The treatment of benign prostate hypertrophy in high risk patients by transurethral Plasmakinetic resection

Objective:In order to evaluate the validity of transurethral plasmakinetic resection of high risk benign prostatic hyperplasia 72 cases were analysed.Methods:72 cases of BPH we retreated by transurethral plasmakinetic resection of prostate (PKRP) and had been followed up at 3 and 14 months.Results:The weight of the prostate was 30-125 g, The mean weight of the prostate was ((59.7)(31.9))g. The operative time was 30-190min, The mean operative time was (6444) min. Peak urine flow in creased form ((7.5)(1.7))ml/s to ((19.2)(3.2))ml/s and I-PSS decreased from ((22.6)(1.5)) to ((7.2)(1.3)) at 3 months postoperatively (P(0.01)).Conclusions:Transurethral plasmakinetic resection of prostate is safe and effective with less complications and good result. It was suggested that the procedure is safe and effective on therapy high risk patients with BPH.